HilleVax
HLVX
HLVX was delisted on the 16th of September, 2025.
81 hedge funds and large institutions have $730M invested in HilleVax in 2024 Q1 according to their latest regulatory filings, with 17 funds opening new positions, 24 increasing their positions, 23 reducing their positions, and 5 closing their positions.
240% more first-time investments, than exits
New positions opened: 17 | Existing positions closed: 5
17% more funds holding
Funds holding: 69 → 81 (+12)
6% more capital invested
Capital invested by funds: $686M → $730M (+$44.4M)
4% more repeat investments, than reductions
Existing positions increased: 24 | Existing positions reduced: 23
0.15% more ownership
Funds ownership: 88.18% → 88.33% (+0.15%)
0% more funds holding in top 10
Funds holding in top 10: 6 → 6 (0)
Top Buyers
| Rank | Fund | Capital Flow |
|---|---|---|
| 1 |
T. Rowe Price Investment Management
Baltimore,
Maryland
|
+$25.7M |
| 2 |
Millennium Management
New York
|
+$10.8M |
| 3 |
Deutsche Bank
Frankfurt Am Main Ge,
Germany
|
+$3.18M |
| 4 |
BM
Bridger Management
New York
|
+$1.73M |
| 5 |
State Street
Boston,
Massachusetts
|
+$1.14M |
Top Sellers
| Rank | Fund | Capital Flow |
|---|---|---|
| 1 |
Morgan Stanley
New York
|
-$13.6M |
| 2 |
DTC
Deep Track Capital
Greenwich,
Connecticut
|
-$5.24M |
| 3 |
B
Braidwell
Stamford,
Connecticut
|
-$3.26M |
| 4 |
Adage Capital Partners
Boston,
Massachusetts
|
-$1.99M |
| 5 |
Vanguard Group
Malvern,
Pennsylvania
|
-$1.63M |
HLVX Hedge Fund Activity: Q1 2024 in Review
81 of the 6,943 institutional investors tracked by Wall St. Rank reported a position in HilleVax (HLVX) for Q1 2024, worth a combined $730M — up 6.5% from $686M a quarter earlier.
Buyers outnumbered sellers: 17 funds opened new HLVX positions and 5 closed out — a net gain of 12 holders — while 24 added to existing stakes and 23 trimmed.
The largest buyer was T. Rowe Price Investment Management, adding an estimated $25.7M. The largest seller was Morgan Stanley, cutting an estimated $13.6M.
- 81 institutional investors held HilleVax (HLVX) as of Q1 2024, up from 69 in Q4 2023.
- Funds reported $730M of HilleVax stock for Q1 2024, up 6.5% quarter-over-quarter.
- 17 funds opened new HilleVax positions in Q1 2024 and 5 closed out, a net change of +12 holders.
- The largest HilleVax buyer in Q1 2024 was T. Rowe Price Investment Management, an estimated $25.7M added.
- The largest HilleVax seller in Q1 2024 was Morgan Stanley, an estimated $13.6M sold.
Based on aggregated 13F filings for Q1 2024.